News
After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company
Hi, what are you looking for?
After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company
With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field
